Pulse Biosciences Announces Two Appointments Focused on CellFX™ Commercialization: Promotion of Edward Ebbers and Addition of Robert Tyson
1/18/19: The leadership pair brings more than 35 years of combined experience commercializing novel technologies in the aesthetic dermatology market and the necessary skillsets to launch and scale the CellFX System and its growing pipeline of applications into the aesthetic dermatology market.
Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed John D. Zehren as the Company’s Chief Commercial Officer, effective as of January 7,...
Dr. Beanlands is a founding member of ASNC, member of its Board of Directors and longtime associate editor of the Journal of Nuclear Cardiology.
1/9/19: Dr. Fallon practiced internal medicine for more than 20 years and served as Senior Vice President and Chief Physician Executive at Blue Cross Blue Shield of Massachusetts ("BCBS MA") from 2004 through 2015.
Dr. David J. Ballard served the past 19 years as Chief Quality Officer of Baylor Scott & White Health the largest health care system in Texas.
1/8/18: Ian Heynen brings more than 15 years of leadership experience working with healthcare companies, most recently as senior vice president of sales and marketing for Profound Medical Corp.
1/7/18: “We are excited to bring John Preston and Greg Dollarhyde to our Board of Directors,” said Robert Ward, CEO of ExThera Medical Corporation.
Martha Shadan has been appointed president and ceo of Miach Orthopaedics. The news was announced today. Shadan brings more than 30 years of medical device executive, marketing and commercialization expertise, and has been executive chairwoman of the...